Stanford scientists have discovered novel high molecular weight isoforms of thymic stromal lymphopoietin (TSLP), measured using nanoimmunoassay (NIA), that can serve as a blood-based biomarker for the diagnosis and prognostication of acute graft versus host disease (aGVHD).
Researchers from Stanford have developed a novel topical pharmaceutical composition comprising of a chemical inhibitor encapsulated in nanomicelles for the treatment of vision loss associated with acute optic neuropathies.
Stanford researchers have developed a targeted antisense oligonucleotide (ASO) platform to restore physiological regulation of DYRK1A, a key driver of neurodevelopmental and neurodegenerative pathology in Down syndrome (Trisomy 21) and other tauopathies.
Researchers at Stanford, in collaboration with UCSF, have developed a two-part approach to preventing preterm birth (PTB), the leading cause of infant mortality worldwide. Current treatments, like low-dose aspirin and progesterone, are limited and often ineffective.
Scientists at Stanford have developed a novel imaging approach that enables high-resolution, label-free visualization of subcellular structures in living cells.
Stanford researchers have developed an innovative nucleic acid amplification method that enables low-cost, multiplexed detection while quantitatively maintaining the original ratios of target genes after amplification.
Researchers at Stanford have developed a platform to design and screen novel chimeric large serine recombinases (LSRs), enzymes capable of inserting large DNA payloads into precise locations in the genome.
Researchers from Stanford developed chemically modified adeno-associated virus (AAV) capsids that enable selective gene delivery to either exocrine or endocrine pancreatic cells through unnatural amino acid incorporation and peptide conjugation.
Researchers at Stanford University have developed a compact insulin pump for continuous subcutaneous insulin infusion (CSII) that addresses a core limitation of many commercial pumps: device size driven by piston-based mechanics.
Researchers at Stanford have created the first small primate model to study human heart rhythm disorders and also discovered a new way the heart keeps its beat.
Stanford researchers have developed a label-free platform that combines surface-enhanced Raman spectroscopy (SERS) with machine learning to enable rapid, non-destructive profiling of cell identity and functional state at single-cell resolution.
Stanford researchers have developed an innovative underwater sensing system inspired by the whiskers of aquatic mammals, enabling robots to detect and track contact with high precision in low-visibility conditions.
Stanford University researchers in the Bamm and Durmus Labs have developed the Dynamic AI-Driven Raman Techniques (DART) platform, which integrates electrochemical enhancement with surface-enhanced Raman spectroscopy for real-time, sensitive, specific, reproducible biomarker d